117 results found.

Head and Neck Cancer, or Colon Cancer Clinical Trial using Head and neck; Colon

Brown University - Recruiting 18 years or older.
- A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer With an Expansion Cohort For Head and Neck Cancer: A Brown University Oncology Research Group Study.
Head and neck; Colon

Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent S Clinical Trial using soy isoflavones; laboratory biomarker analysis; survey administration

National Cancer Institute (NCI) - Recruiting 19 years to 79 years.
- A Phase II Trial of Preoperative Soy Isoflavone Supplementation and Molecular Markers in the Prevention of Head and Neck Squamous Carcinoma.
soy isoflavones; laboratory biomarker analysis; survey administration

Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck Clinical Trial using CC-115

Celgene Corporation - Recruiting 18 years or older.
- A Phase 1a/b, Multicenter, Open Label, Dose-Finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the Dual DNA-PK and TOR Kinase Inhibitor, CC-115, Administered Orally to Subjects With Advanced Solid Tumors, and Hematologic Malignancies..
CC-115

Head and Neck Neoplasms Clinical Trial using methotrexate; afatinib

Boehringer Ingelheim - Recruiting 18 years or older.
- A Randomised, Open-label, Phase III Study to Evaluate the Efficacy and Safety of Oral Afatinib (BIBW 2992) Versus Intravenous Methotrexate in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Who Have Progressed After Platinum-based Therapy.
methotrexate; afatinib

Head and Neck Neoplasms Clinical Trial using Placebo; Afatinib

Boehringer Ingelheim - Recruiting 18 years or older.
- A Randomised, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of Afatinib (BIBW 2992) as Adjuvant Therapy After Chemo-radiotherapy in Primary Unresected Patients With Stage III, IVa, or IVb Loco-regionally Advanced Head and Neck Squamous Cell Carcinoma.
Placebo; Afatinib

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Clinical Trial using tivantinib; cetuximab; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Randomized Phase II Trial of ARQ 197 (Tivantinib) /Cetuximab Versus Cetuximab in Patients With Recurrent/Metastatic Head and Neck Cancer.
tivantinib; cetuximab; laboratory biomarker analysis

Head and Neck Cancer Clinical Trial using MEHD7945A; cisplatin; 5-FU; carboplatin; paclitaxel

Genentech - Recruiting 18 years or older.
- A Phase 1b Open-Label Study of the Safety and Pharmacokinetics of MEHD7945A in Combination With Either Cisplatin and 5-FU or Paclitaxel and Carboplatin in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.
MEHD7945A; cisplatin; 5-FU; carboplatin; paclitaxel

Head And Neck Cancer Clinical Trial using Intensity-Modulated X-Ray Therapy (IMRT); Intensity-Modulated Proton Beam Therapy (IMPT); Modified barium swallow (MBS); Questionnaires

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Phase II/III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck Cancer.
Intensity-Modulated X-Ray Therapy (IMRT); Intensity-Modulated Proton Beam Therapy (IMPT); Modified barium swallow (MBS); Questionnaires

Cetuximab-induced Papulopustular (Acneiform) Rash Who Have, or Me Clinical Trial using Topical Dapsone 5% Gel; Moisturizer; oral antibiotics

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase III Randomized Double-blind Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT.
Topical Dapsone 5% Gel; Moisturizer; oral antibiotics

Head and Neck Cancer Clinical Trial using Collect Blood and Survey Instruments

UNC Lineberger Comprehensive Cancer Center - Recruiting 65 years or older.
- Identification of Predictors of Tolerance to Chemoradiotherapy in Elderly Patients With Head and Neck Cancer.
Collect Blood and Survey Instruments

Head and Neck Cancer Clinical Trial using Chart Review; Questionnaires

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Prospective Data Collection of Patients Treated With Proton Therapy for Head and Neck Malignancies.
Chart Review; Questionnaires

Squamous Cell Carcinoma, or Head and Neck Cancer Clinical Trial using EGFR Antisense DNA

The University of Texas Health Science Center at San Antonio - Recruiting 18 years or older.
- Safety and Efficacy of Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.
EGFR Antisense DNA

Head and Neck Cancer, or Squamous Cell Carcinoma of the Head and Clinical Trial using Cisplatin; Docetaxel; Erlotinib; Placebo; Carboplatin

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- A Randomized, Placebo-Controlled, Phase 2 Study of Docetaxel And Cisplatin With Or Without Erlotinib In Patients With Metastatic Or Recurrent Squamous Cell Carcinoma Of the Head And Neck.
Cisplatin; Docetaxel; Erlotinib; Placebo; Carboplatin

Carcinoma, Squamous Cell of Head and Neck Clinical Trial using Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed by Concurrent Radiation, Cisplatin, Cetuximab and Bevacizumab (XPE-A), surgery

The University of Texas Health Science Center at San Antonio - Recruiting 18 years or older.
- A Phase II Study of Induction Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed by Concurrent Radiation, Cisplatin, Cetuximab and Bevacizumab (XPE-A) in Patients With Locally Advanced Head and Neck Cancer (CTRC# 11-36).
Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed by Concurrent Radiation, Cisplatin, Cetuximab and Bevacizumab (XPE-A), surgery

Head and Neck Neoplasms Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 21 years or older.
- Pilot Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan.

Head and Neck Squamous Cell Carcinoma Clinical Trial using Paclitaxel; Carboplatin; Cetuximab; Docetaxel; Cisplatin; Fluorouracil; Radiotherapy (RT); Chemotherapy

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Randomized Phase II Trial Contrasting Weekly Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.
Paclitaxel; Carboplatin; Cetuximab; Docetaxel; Cisplatin; Fluorouracil; Radiotherapy (RT); Chemotherapy

Head and Neck Cancer Clinical Trial using LUZ11

Luzitin SA - Recruiting 18 years or older.
- An Open-label Study to Investigate the Tolerability, Pharmacokinetics and Anti-tumour Effect Following Photodynamic Therapy (PDT) With Single-ascending Doses of LUZ11 in Patients With Advanced Head and Neck Cancer.
LUZ11

Head and Neck Cancer Clinical Trial using Docetaxel; Cisplatin; Cetuximab; Carboplatin

Stanford University - Recruiting 16 years or older.
- Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With SCCHN.
Docetaxel; Cisplatin; Cetuximab; Carboplatin

Head and Neck Neoplasms, Lung Neoplasms, Urinary Bladder Neoplasm Clinical Trial using Tetrahydrouridine (THU); [F-18]-5-FLUORO-2'-DEOXYCYTIDINE

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Phase 0 Trial of [F-18]-5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine.
Tetrahydrouridine (THU); [F-18]-5-FLUORO-2'-DEOXYCYTIDINE

Squamous Cell Carcinoma of the Oral Cavity, or Squamous Cell Carc Clinical Trial using GC4419

Galera Therapeutics, Inc. - Recruiting 18 years or older.
- A Phase 1 Dose Escalation Study of GC4419 in Combination With Radiation and Chemotherapy for Squamous Cell Cancers of the Head and Neck..
GC4419

Head and Neck Cancer Clinical Trial using everolimus; laboratory biomarker analysis

Yonsei University - Recruiting 18 years or older.
- An Open Label Multi-Center Phase II Study of RAD001 in Advanced Thyroid Cancer.
everolimus; laboratory biomarker analysis

Head and Neck Cancer, Oral Cavity Cancer, or Oropharyngeal Cancer Clinical Trial using Valproic Acid

Instituto do Cancer do Estado de Sao Paulo - Recruiting N/A to 65 years.
- Efficacy Evaluation of the Combination of Valproic Acid and Standard Platinum-based Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.
Valproic Acid

Neck Cancer Clinical Trial using APA

University Hospital, Limoges - Recruiting 18 years or older.
- Feasibility Study: Physical Activity Program Associated Wtih Nutrition Therapeutic Education in Head and Neck Cancer Population Treating by Chemotherapy With or Without Radiotherapy..
APA

Head and Neck Cancer, Lung Cancer, Lip Cancer, Lip Neoplasms, or Clinical Trial using Tumor biopsy; Phlebotomy

Stanford University - Recruiting 18 years or older.
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers.
Tumor biopsy; Phlebotomy

Head and Neck Cancer Clinical Trial

Stanford University - Recruiting 18 years or older.
- Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer.

Head-neck Cancer Clinical Trial using Intensive nutritional counseling; Nutritional counseling

IRCCS Policlinico S. Matteo - Recruiting 18 years or older.
- Intensive Nutritional Counseling in Head-neck Cancer Patients Undergoing Radiotherapy: a Randomized, Controlled Trial.
Intensive nutritional counseling; Nutritional counseling

Head and Neck Cancer Clinical Trial using Proflavine; Imaging; Widefield Multispectral Imaging Devices; High-Resolution Microendoscope (HRME)

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Wide-Field and High Resolution In Vivo Imaging of Oral Neoplasia Using Topical Fluorescent Dyes: A Feasibility Study.
Proflavine; Imaging; Widefield Multispectral Imaging Devices; High-Resolution Microendoscope (HRME)

Head and Neck Cancer Clinical Trial using F-MISO PET scan

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients.
F-MISO PET scan

Oral Mucositis Clinical Trial using Clonidine Lauriadr 50æg; Clonidine Lauriadr 100æg; Placebo Lauriadr

BioAlliance Pharma SA - Recruiting 18 years or older.
- A Phase II, Multi-center, Randomised, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Lauriadr 50 æg and 100 æg Mucoadhesive Buccal Tablet (MBT) Applied Once Daily to Those of Placebo in the Prevention and Treatment of Chemoradiation Therapy Induced Oral Mucositis in Patients With Head and Neck Cancer.
Clonidine Lauriadr 50æg; Clonidine Lauriadr 100æg; Placebo Lauriadr

Advanced Stage Head and Neck Cancer Clinical Trial using Quality of Life Questionaires & Interview: EORTC QLQ C-30, EORTC QLQ H&N-35, Health Behaviors, Subjective Significance Questionnaire, Qualitative Assessment

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- RECONSTRUCTIVE SURGERY For Head And Neck Cancer Patients: A Prospective Analysis Of Quality Of Life And Symptom Relief.
Quality of Life Questionaires & Interview: EORTC QLQ C-30, EORTC QLQ H&N-35, Health Behaviors, Subjective Significance Questionnaire, Qualitative Assessment

Head and Neck Cancer Clinical Trial using Flexible Fiber-based CO2 Laser, Quality of Life forms; electrocautery resection and quality of life forms

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Flexible Fiber-based CO2 Laser Versus Monopolar Cautery for Resection of Benign, Pre-malignant And Malignant Oral Cavity Lesions: A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery.
Flexible Fiber-based CO2 Laser, Quality of Life forms; electrocautery resection and quality of life forms

Carcinoma Clinical Trial

Onkovis GmbH - Recruiting N/A or older.
- Open, Multicenter Observational Study of Docetaxel Utilized in Mono- or Combination Therapy for Treatment of Breast Cancer, NSCLC, Prostate Carcinoma, Adenocarcinoma of Stomach and Advanced Squamous Cell Carcinoma of Head/Neck Region..

Recurrent, or Head and Neck Cancer Clinical Trial using SBRT; Cetuximab; Docetaxel

University of Pittsburgh - Recruiting 18 years or older.
- Randomized Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated Squamous Cell Carcinoma of the Head and Neck (SCCHN).
SBRT; Cetuximab; Docetaxel

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Clinical Trial using afatinib; placebo; laboratory biomarker analysis

Eastern Cooperative Oncology Group - Recruiting 18 years or older.
- A Randomized, Placebo Controlled Phase II Trial of Afatinib (BIBW2992) as Adjuvant Therapy Following Chemoradiation in Patients With Head and Neck Squamous Cell Carcinoma at High Risk of Recurrence.
afatinib; placebo; laboratory biomarker analysis

Head and Neck Cancer Clinical Trial using 6 weeks of Radiotherapy; 5 weeks of Radiotherapy

University of California, Davis - Recruiting 18 years or older.
- Phase II Trial Of Induction Chemotherapy Followed By Attenuated Chemoradiotherapy For Locally Advanced Head And Neck Squamous Cell Carcinoma Associated With Human Papillomavirus (HPV).
6 weeks of Radiotherapy; 5 weeks of Radiotherapy

Carcinoma, Squamous Cell, Head and Neck Neoplasms, or Oropharynge Clinical Trial using Assessment of Oral HPV Infection

UNC Lineberger Comprehensive Cancer Center - Recruiting 18 years or older.
- Monitoring of Oral HPV Infection in HPV-positive Oropharyngeal Squamous Cell Carcinoma During and After Chemoradiotherapy (CRT).
Assessment of Oral HPV Infection

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Clinical Trial using TLR8 agonist VTX-2337; cetuximab; laboratory biomarker analysis; pharmacogenomic studies

University of Washington - Recruiting 18 years or older.
- Phase I Clinical Trial of VTX-2337, a Small Molecule Toll-Like Receptor 8 (TLR8) Agonist in Combination With Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinomas of the Head and Neck (SCCHN).
TLR8 agonist VTX-2337; cetuximab; laboratory biomarker analysis; pharmacogenomic studies

Head and Neck Cancer Clinical Trial using Everolimus (RAD 001) or placebo

University of Chicago - Recruiting 18 years or older.
- Randomized Phase II Trial of Everolimus Versus Placebo as Adjuvant Therapy in Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN).
Everolimus (RAD 001) or placebo

Head and Neck Cancer Clinical Trial using Everolimus escalating dose; Everolimus or Placebo

University of Chicago - Recruiting 18 years to 89 years.
- Selection of Chemoradiotherapy Based on Response to Induction Chemotherapy - a Phase II Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck.
Everolimus escalating dose; Everolimus or Placebo

Cancer Liver, Cancer Brain, Cancer Head &Neck, or Cancer Pelvis Clinical Trial using MRI Group

University of Michigan Cancer Center - Recruiting 18 years or older.
- Optimization of MRI for Radiation Therapy.
MRI Group

Breast Cancer, Brain Cancer, Gastrointestinal Cancers, Genitourin Clinical Trial using IGF-Methotrexate

University of Illinois at Chicago - Recruiting 18 years or older.
- STM-02: Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R.
IGF-Methotrexate

Head and Neck Cancer, or Prostate Cancer Clinical Trial using MRI scanner with sequence

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers.
MRI scanner with sequence

Mouth Neoplasms, Head and Neck Neoplasms, Tongue Neoplasms, or Ca Clinical Trial using Rapamycin; Biopsy; Dynamic CT Perfusion; Positron Emission Tomography; Measurement Serum Cytokines

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 80 years.
- A Pilot Trial Targeting mTOR as a Novel Mechanism-Based Neoadjuvant Therapy for Head and Neck Cancer.
Rapamycin; Biopsy; Dynamic CT Perfusion; Positron Emission Tomography; Measurement Serum Cytokines

Head and Neck Cancer, Squamous Cell Carcinoma of the Head and Nec Clinical Trial using ADXS11-001 (ADXS-HPV)

Mount Sinai School of Medicine - Recruiting 18 years or older.
- Window of Opportunity Trial of Neoadjuvant ADXS 11-001 Vaccination Prior to Robot -Assisted Resection of HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
ADXS11-001 (ADXS-HPV)

Skin Cancer of the Head and Neck Clinical Trial

University of Florida - Recruiting 18 years or older.
- A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Carcinoma of the Skin of the Head and Neck With Perineural Invasion.

Recurrent Squamous Cell Carcinoma of the Nasopharynx, or Stage IV Clinical Trial using Akt inhibitor MK2206; pharmacological study; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma.
Akt inhibitor MK2206; pharmacological study; laboratory biomarker analysis

Head and Neck Cancer Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Evaluation for NIDCD Head & Neck Surgery Branch Clinical Research Protocols.

Gastro-intestinal Cancer, Lung Cancer, Head and Neck Cancer, or B Clinical Trial using Instructed to read patient education pamphlets

Sunnybrook Health Sciences Centre - Recruiting 18 years or older.
- The Impact of a Patient Education Intervention on Knowledge, Self-efficacy, Symptom Burden, Health Related Quality of Life and Satisfaction With the Experience of Care for Oncology Ambulatory Patients Post Completion of the Edmonton Screening Assessment System.
Instructed to read patient education pamphlets

Head and Neck Neoplasms Clinical Trial using Ketogenic diet

University of Iowa - Recruiting 18 years or older.
- A Phase I Trial of a Ketogenic Diet With Concurrent Chemoradiation for Head and Neck Cancer.
Ketogenic diet

Cancer, Melanoma, Breast Cancer, Head and Neck Cancer, or Lymphom Clinical Trial using LTX-315

Lytix Biopharma AS - Recruiting 18 years or older.
- A Phase I, Open-label, Multi-centre, Multi-dose, Dose Escalation Study of LTX-315 in Patients With Transdermally Accessible Tumours.
LTX-315

Head and Neck Cancer Clinical Trial using Dynamic Contrast Enhanced CT scan

Lawson Health Research Institute - Recruiting 18 years or older.
- Dynamic Contrast Enhanced Computed Tomography (DCE-CT) to Assess Lymph Node Metastases in Head and Neck Cancer: A Prospective Study.
Dynamic Contrast Enhanced CT scan

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III S Clinical Trial using cisplatin; docetaxel; cetuximab; laboratory biomarker analysis; quality-of-life assessment; intensity-modulated radiation therapy

Radiation Therapy Oncology Group - Recruiting 18 years or older.
- Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck.
cisplatin; docetaxel; cetuximab; laboratory biomarker analysis; quality-of-life assessment; intensity-modulated radiation therapy

Non-HPV Locally Advanced Head and Neck Cancer Clinical Trial using intensity modulated radiation therapy; Cisplatin; placebo; Lapatinib

Radiation Therapy Oncology Group - Recruiting 18 years or older.
- TRYHARD: A Phase II, Randomized, Double Blind, Placebo-Controlled Study of Lapatinib (Tykerbr) for Non-HPV Locally Advanced Head and Neck Cancer With Concurrent Chemoradiation.
intensity modulated radiation therapy; Cisplatin; placebo; Lapatinib

Platinum Pre-treated Recurrent or Metastatic Head and Neck Squamo Clinical Trial using Paclitaxel; Buparlisib; Buparlisib Placebo

Novartis - Recruiting 18 years or older.
- Double Blind, Placebo Controlled Study Assessing the Efficacy of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Patients With Platinum Pre-treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC).
Paclitaxel; Buparlisib; Buparlisib Placebo

HPV-related Head and Neck Cancer Clinical Trial using pNGVL-4a-CRT/E7 (detox) DNA vaccine

Sidney Kimmel Comprehensive Cancer Center - Recruiting 18 years to 75 years.
- A Phase I Clinical Trial Assessing the Safety and Feasibility of Administration of pNGVL4a-CRT/E7(Detox) DNA Vaccine Using the Intramuscular TriGridTM Delivery System in Combination With Cyclophosphamide in HPV-16 Associated Head and Neck Cancer Patients.
pNGVL-4a-CRT/E7 (detox) DNA vaccine

Oral Mucositis Clinical Trial using SGX942; Placebo

Soligenix - Recruiting 18 years or older.
- A Phase 2,Double-Blind, Randomized, Placebo-Controlled, Dose Escalating, Multicenter Study of SGX942 For the Attenuation of Oral Mucositis in Patients Being Treated With Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck.
SGX942; Placebo

Head and Neck Cancer, or Precancerous Condition Clinical Trial using cetuximab; cisplatin

Radiation Therapy Oncology Group - Recruiting 18 years or older.
- Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer.
cetuximab; cisplatin

Head and Neck Cancer, Pharyngeal Cancer, or Laryngeal Cancer Clinical Trial using Nutrition Counseling; Resistance Training

University of Alabama at Birmingham - Recruiting 19 years to 75 years.
- Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer.
Nutrition Counseling; Resistance Training

Head and Neck Cancer, or Squamous Cell Cancer Clinical Trial using Afatinib, Ribavirin, and weekly carboplatin/paclitaxel

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase I Study of Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC).
Afatinib, Ribavirin, and weekly carboplatin/paclitaxel

Head and Neck Cancers Clinical Trial using Cerenkov emissions from the PET tracer 18F-FDG and the radiotherapeutic 131I

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes.
Cerenkov emissions from the PET tracer 18F-FDG and the radiotherapeutic 131I

Head and Neck Cancer Clinical Trial using Indocyanine Green

Jules Bordet Institute - Recruiting 18 years or older.
- Near-infrared Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After Intravenous Injection of Indocyanine Green (a Feasibility Study).
Indocyanine Green

Metastatic or Recurrent HNSCC Clinical Trial using Carbo, 5FU, Cetuximab

Groupe Oncologie Radiotherapie Tete et Cou - Recruiting 70 years or older.
- Phase II Multicenter Trial Evaluating First Line Carboplatin, 5-Fluorouracil and Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer, Aged 70 and Over, Ranked as Fit (no Frailty) by Geriatric Assessment.
Carbo, 5FU, Cetuximab

Head Neck Cancer Squamous Cell Clinical Trial using Erbitux

Groupe Oncologie Radiotherapie Tete et Cou - Recruiting 18 years to 75 years.
- A Phase II Study, Multicenter, to Evaluate the Efficacy and Safety of the Combination of Reirradiation - Erbitux in Subjects Previously Irradiated and With a Local Recurrent Inoperable Squamous Cell Cancer of the Head and Neck.
Erbitux

Oral Cancer, Oropharynx Cancer, or Hypopharynx Cancer Clinical Trial using IMRT 75 Gy; Conventional radiotherapy 70 Gy; concomitant cisplatin

Groupe Oncologie Radiotherapie Tete et Cou - Recruiting 18 years or older.
- Phase III Trial of Intensity-modulated Radiotherapy Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma.
IMRT 75 Gy; Conventional radiotherapy 70 Gy; concomitant cisplatin

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Clinical Trial using docetaxel; cisplatin; carboplatin; fluorouracil; bevacizumab

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.
docetaxel; cisplatin; carboplatin; fluorouracil; bevacizumab

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrent Disease, Clinical Trial using BKM120

Centre Leon Berard - Recruiting 18 years or older.
- A Phase II, Multicenter Trial Aiming to Evaluate the Clinical Interest of a Monotherapy With BKM120 , a PI3K Inhibitor in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive Under Platin and Cetuximab-based Chemotherapy.
BKM120

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III S Clinical Trial using cetuximab; intensity-modulated radiation therapy; ipilimumab; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase Ib Trial of Concurrent Cetuximab (ERBITUXr) and Intensity Modulated Radiotherapy (IMRT) With Ipilimumab (YERVOYr) in Locally Advanced Head and Neck Cancer.
cetuximab; intensity-modulated radiation therapy; ipilimumab; laboratory biomarker analysis

Head and Neck Cancer, Long-term Effects Secondary to Cancer Thera Clinical Trial using Acupuncture

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients With Head and Neck Cancer.
Acupuncture

Colorectal Cancer, or Head and Neck Cancer Clinical Trial using Doxycycline; Hydrocortisone 1% cream; Sunscreen; Moisturizer; Clindamycin; Medrol-dose pack (Steroid)

James Graham Brown Cancer Center - Recruiting 18 years or older.
- Preemptive Therapy Study of Cetuximab(Erbituxr)Induced Skin Rash Using Doxycycline, Sunscreen, Hydrocortisone and Moisturizer in Colorectal and Head and Neck Cancer Patients.
Doxycycline; Hydrocortisone 1% cream; Sunscreen; Moisturizer; Clindamycin; Medrol-dose pack (Steroid)

Cancer of Head and Neck Clinical Trial using concurrent chemo + IGRT; neoadjuvant chemo + IGRT

Beth Israel Medical Center - Recruiting 18 years or older.
- Kilovoltage Conebeam Imaging Based Adaptive Radiation Therapy for Head & Neck Patients Treated With Intensity Modulated Radiation Therapy.
concurrent chemo + IGRT; neoadjuvant chemo + IGRT

Head and Neck Cancer Clinical Trial using Cetuximab; Radiation Therapy

University of Cincinnati - Recruiting 18 years or older.
- Phase II Trial of Post-operative or Definitive Concurrent Radiation and Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Cetuximab; Radiation Therapy

Colon Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Malign Clinical Trial using magnetic resonance imaging with positron emission tomography scanning

Case Comprehensive Cancer Center - Recruiting N/A or older.
- Evaluating Attenuation Correction Methods Applied to PET/MRI.
magnetic resonance imaging with positron emission tomography scanning

Colorectal Cancer, or Head and Neck Cancer Clinical Trial using Nilotinib + Cetuximab

Georgetown University - Recruiting 18 years or older.
- A Phase I Study of the BCR-ABL Tyrosine Kinase Inhibitor Nilontinib and Cetuximab in Patients With Solid Tumors That Can be Treated With Cetuximab.
Nilotinib + Cetuximab

Carcinoma, Squamous Cell of Head and Neck Clinical Trial using Afatinib; Observation

European Organisation for Research and Treatment of Cancer - EORTC - Recruiting 18 years or older.
- Neoadjuvant Afatinib Based Treatment Strategies Followed by Surgery in Squamous Cell Carcinoma of the Head and Neck: an EORTC NOCI-HNCG Window Study..
Afatinib; Observation

Squamous Cell Carcinoma of the Head and Neck Clinical Trial using Olaparib; Cetuximab; Radiation Therapy

University of Colorado, Denver - Recruiting 18 years or older.
- Phase I Trial of Olaparib (AZD2281) in Combination With C225 and Radiation Therapy in Patients With Locally Advanced, Stage IVA-B Squamous Cell Carcinomas of the Head/Neck With Heavy Smoking Histories.
Olaparib; Cetuximab; Radiation Therapy

Head and Neck Cancer, or Head and Neck Squamous Cell Carcinoma Clinical Trial using Cyclophosphamide; Cetuximab

Masonic Cancer Center, University of Minnesota - Recruiting 18 years or older.
- Potentiation of Cetuximab by Tregs Depletion With Metronomic Cyclophosphamide in Metastatic Squamous Cell Cancers of Head and Neck.
Cyclophosphamide; Cetuximab

Head and Neck Squamous Cell Carcinoma Clinical Trial using Resistance Exercise Training (RET)

University of Michigan Cancer Center - Recruiting 18 years or older.
- Benefits of Resistance Exercise Training in Locally Advanced Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy.
Resistance Exercise Training (RET)

Head and Neck Cancer Clinical Trial using Panitumumab; Cisplatin; Radiation Therapy

University of Pittsburgh - Recruiting 18 years or older.
- A Phase II Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer.
Panitumumab; Cisplatin; Radiation Therapy

Stage I Squamous Cell Carcinoma of the Oropharynx, Stage II Squam Clinical Trial using questionnaire administration; quality-of-life assessment

University of Chicago - Recruiting 18 years or older.
- Patient Preferences in Head and Neck Cancer Treatment Decisions - a Pilot Study of the Durability of Patient Priorities.
questionnaire administration; quality-of-life assessment

Cancer of the Head and Neck Clinical Trial using Injection of [18F]HX4

Maastricht Radiation Oncology - Recruiting 18 years or older.
- Non Invasive Imaging of [18F]HX4 With Positron-Emission-Tomography (PET) in Head and Neck Cancer..
Injection of [18F]HX4

Oral Cancer Clinical Trial

Roswell Park Cancer Institute - Recruiting 21 years or older.
- Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression.

Squamous Cell Carcinoma of the Head and Neck Clinical Trial using Afatinib; Paclitaxel; Carboplatin; Cisplatin; Intensity Modulated Radiation Therapy

Sidney Kimmel Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy Followed By Standard Chemoradiation In HPV-Negative or High-risk HPV-Positive Locally Advanced Stage III/IVa/IVb HNSCC.
Afatinib; Paclitaxel; Carboplatin; Cisplatin; Intensity Modulated Radiation Therapy

Stage III Squamous Cell Carcinoma of the Oropharynx, or Stage IV Clinical Trial using vorinostat; cisplatin; radiation therapy; Correlative Studies

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase I Trial Of Vorinostat In The Treatment Of Advanced Laryngeal, Hypopharyngeal, Nasopahryngeal And Oropharyngeal Squamous Cell Carcinoma Of The Head And Neck..
vorinostat; cisplatin; radiation therapy; Correlative Studies

Head and Neck Cancer Clinical Trial using positron emission tomography/computed tomography; therapeutic conventional surgery

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Multi-centre Randomised Phase III Trial Comparing PET-CT Guided Watch and Wait Policy Versus Planned Neck Dissection for the Management of Locally Advanced (N2/N3) Nodal Metastases in Patients With Head and Neck Squamous Cancer.
positron emission tomography/computed tomography; therapeutic conventional surgery

Breast Cancer, Colorectal Cancer, Esophageal Cancer, Head and Nec Clinical Trial using 18F-fluoromisonidazole; fluorescence angiography; laboratory biomarker analysis; infrared thermography; magnetic resonance imaging; therapeutic conventional surgery; [18F]-ML-10; fludeoxyglucose F 18; rubidium Rb-82

National Cancer Institute (NCI) - Recruiting N/A or older.
- Tumor Angiogenesis in Non-Small Cell Lung (NSCLC), Colorectal, Breast, Esophageal, Head and Neck Cancer: Radiology-Pathology and Prognostic Correlation.
18F-fluoromisonidazole; fluorescence angiography; laboratory biomarker analysis; infrared thermography; magnetic resonance imaging; therapeutic conventional surgery; [18F]-ML-10; fludeoxyglucose F 18; rubidium Rb-82

Head and Neck Cancer Clinical Trial using Cetuximab; 50-60 Gy and 70 Gy

University of Michigan Cancer Center - Recruiting 70 years or older.
- Phase II Study of RT Concurrent w/ Cetuximab in Patients w/ Locally Advanced Head & Neck SCC Who Do Not Qualify For Standard Chemotherapy Due To Age >70 Or Co-Morbidities.
Cetuximab; 50-60 Gy and 70 Gy

Hypopharyngeal Cancer Clinical Trial using neoadjuvant docetaxel/cisplatin/fluorouracil; No treatment before definitive CCRT

Samsung Medical Center - Recruiting 18 years or older.
- Concurrent Chemoradiation Versus Induction Docetaxel, Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy in Locally Advanced Hypopharyngeal and Base of Tongue Cancer: A Randomized Phase II Study.
neoadjuvant docetaxel/cisplatin/fluorouracil; No treatment before definitive CCRT

Head and Neck Cancer Clinical Trial using Intra-arterial cisplatin; Intravenous cisplatin

Southern Illinois University - Recruiting 18 years or older.
- A Pilot/ Feasibility Study Comparing Response Rates of Intra-arterial and Intravenous Cisplatin Chemotherapy, Combined With Radiation, in Patients With Locally Advanced Carcinoma of the Oral Cavity and Oropharynx.
Intra-arterial cisplatin; Intravenous cisplatin

Cancer of Head and Neck Clinical Trial using Cetuximab/IMRT Plus Ipilimumab

University of Pittsburgh - Recruiting 18 years or older.
- A Phase Ib Trial of Concurrent Cetuximab (ERBITUXr) and Intensity Modulated Radiotherapy (IMRT) With Ipilimumab (YERVOYr) in Locally Advanced Head and Neck Cancer.
Cetuximab/IMRT Plus Ipilimumab

Squamous Cell Carcinoma of the Head and Neck Clinical Trial using 18F-EF5; Pretreatment PET/CT-scan (performed two times)

Turku University Hospital - Recruiting 18 years to 80 years.
- Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer.
18F-EF5; Pretreatment PET/CT-scan (performed two times)

Head and Neck Cancer Clinical Trial using bandage skin Hydrosorb; Biafiner

Centre Francois Baclesse - Recruiting 18 years to 69 years.
- Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy.
bandage skin Hydrosorb; Biafiner

Head and Neck Cancer, or Squamous Cell Carcinoma of the Head and Clinical Trial using Carboplatin; Paclitaxel; Lapatinib; Cisplatin; Ipsilateral Radiation; Bilateral Radiation; Transoral Surgery

UNC Lineberger Comprehensive Cancer Center - Recruiting 18 years or older.
- Multimodality Risk Adapted Therapy Including Carboplatin/Paclitaxel/Lapatinib as Induction for Squamous Cell Carcinoma of the Head and Neck Amenable to Transoral Surgical Approaches.
Carboplatin; Paclitaxel; Lapatinib; Cisplatin; Ipsilateral Radiation; Bilateral Radiation; Transoral Surgery

Primary Non-operated Squamous Cell Carcinoma of Oral Cavity, Prim Clinical Trial using video fluoroscopy; extra imaging; scoring acute toxicity; scoring of late toxicity; scoring quality of life (QOL)

University Hospital, Ghent - Recruiting 18 years or older.
- Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective Neck: a Multicenter, Two-arm, Randomized Phase II Trial..
video fluoroscopy; extra imaging; scoring acute toxicity; scoring of late toxicity; scoring quality of life (QOL)

Recurrent and Second Primary Squamous Cell Carcinoma of the Oral Clinical Trial using [18F]FDG-PET-voxel intensity-based IMRT

University Hospital, Ghent - Recruiting 18 years or older.
- A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory..
[18F]FDG-PET-voxel intensity-based IMRT

Head and Neck Cancer Clinical Trial using DCE-MRI, DW-MRI and MRS

Oregon Health and Science University - Recruiting 18 years or older.
- Pilot Study of DCE-MRI, DW-MRI, and MRS in the Assessment of Head and Neck Cancer Response to Chemo-radiation.
DCE-MRI, DW-MRI and MRS

Head and Neck Cancer Clinical Trial using Nimotuzumab; Cisplatin; Radiation

National Cancer Centre, Singapore - Recruiting 21 years to 70 years.
- Phase II Study of Nimotuzumab (TheraCim-hR3) Concurrent With Cisplatin/Radiotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC).
Nimotuzumab; Cisplatin; Radiation

Head and Neck Squamous Cell Carcinoma Clinical Trial using Tadalafil; Placebo

Sidney Kimmel Comprehensive Cancer Center - Recruiting 21 years or older.
- A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract.
Tadalafil; Placebo

Abnormalities, Radiation-Induced Clinical Trial

University Health Network, Toronto - Recruiting 18 years or older.
- Optical Coherence Tomography for Monitoring Late Oral Radiation Toxicity After Radiotherapy of Head and Neck Cancer Patients.

Head and Neck Cancer Clinical Trial using ABI-007

University Health Network, Toronto - Recruiting 18 years or older.
- Phase I Trial of ABI-007 (Abraxane) Plus Cisplatin Plus 5-Fluorouracil (APF) as Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With Locally Advanced Squamous Cell Cancers of the Head and Neck (HNSCC).
ABI-007

Head and Neck Cancer, or Precancerous Condition Clinical Trial using aminolevulinic acid hydrochloride

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Photodynamic Therapy for Premalignant and Early Stage Head and Neck Tumors.
aminolevulinic acid hydrochloride

Head and Neck Neoplasms Clinical Trial

Technische Universit„t Dresden - Recruiting 18 years to 70 years.
- Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO.

Head and Neck Cancer Clinical Trial

Technische Universit„t Dresden - Recruiting 18 years to 70 years.
- .

Head and Neck Cancer Clinical Trial using Cisplatin; Elective Nodal Irradiation (ENI)

New Hanover Regional Medical Center - Recruiting 18 years or older.
- Chemoradiotherapy With Very Low Dose Elective Nodal IMRT for Locally Advanced Head & Neck Cancer: the CCRO11 Multi-Institutional Phase II Trial.
Cisplatin; Elective Nodal Irradiation (ENI)

Head and Neck Cancer Clinical Trial using chemotherapy; diagnostic laboratory biomarker analysis; tissue oxygen measurement; blood-oxygen-level-dependent functional magnetic resonance imaging; dynamic contrast-enhanced magnetic resonance imaging; magnetic resonance spectroscopic imaging; radiation therapy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Predicting Treatment Response Based on Hypoxia in Head and Neck Cancers Using Non-Invasive Oxygen Sensitive MRI.
chemotherapy; diagnostic laboratory biomarker analysis; tissue oxygen measurement; blood-oxygen-level-dependent functional magnetic resonance imaging; dynamic contrast-enhanced magnetic resonance imaging; magnetic resonance spectroscopic imaging; radiation therapy

Head and Neck Cancer, Infection, or Malnutrition Clinical Trial using therapeutic nutritional supplementation; placebo

National Cancer Institute (NCI) - Recruiting 18 years to 75 years.
- Role of Peri-operative Immunonutrition in Cancers of the Higher Aero-digestive Tract.
therapeutic nutritional supplementation; placebo

Head and Neck Cancer Clinical Trial using TPF, radiotherapy and cisplatin.; TPF, radiotherapy and cetuximab.

Grupo Espa¤ol de Tratamiento de Tumores de Cabeza y Cuello - Recruiting 18 years to 70 years.
- Open Label Randomized, Multi-centre Phase III Trial of TPF Plus Conc. Treatment With Cisplatin and Radiotherapy Versus Conc. Cetuximab and Radiotherapy in Locally Advanced, Unresectable Head and Neck Cancer..
TPF, radiotherapy and cisplatin.; TPF, radiotherapy and cetuximab.

Head and Neck Cancer Clinical Trial using TPF, radiotherapy and cetuximab; H&N surgery

Grupo Espa¤ol de Tratamiento de Tumores de Cabeza y Cuello - Recruiting 18 years to 70 years.
- A Phase II Trial With Radiotherapy Plus Cetuximab to Evaluate Specific Survival Free of Laryngectomy in Patients With Resectable and Locally Advanced Larynx Cancer, After Treatment With TPF.
TPF, radiotherapy and cetuximab; H&N surgery

Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, or Clinical Trial using cetuximab (associated with radiotherapy); cisplatin (associated to radiotherapy)

Azienda USL 4 Prato - Recruiting 18 years or older.
- Multiinstitutional Open Label Randomized Phase II Study Comparing Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy as Firstline Treatment for Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-NHSCC).
cetuximab (associated with radiotherapy); cisplatin (associated to radiotherapy)

Head and Neck Cancer, Ototoxicity, or Radiation Toxicity Clinical Trial using adjuvant therapy; assessment of therapy complications; quality-of-life assessment; 3-dimensional conformal radiation therapy; intensity-modulated radiation therapy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Multicenter Randomized Study of Cochlear Sparing Intensity Modulated Radiotherapy Versus Conventional Radiotherapy in Patients With Parotid Tumors.
adjuvant therapy; assessment of therapy complications; quality-of-life assessment; 3-dimensional conformal radiation therapy; intensity-modulated radiation therapy

Carcinomas Clinical Trial using Escitalopram

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years to 75 years.
- .
Escitalopram

Squamous Cell Carcinoma, or Head and Neck Cancer Clinical Trial using MAGE-A3 HPV-16 vaccine

University of Maryland - Recruiting 18 years or older.
- A Phase 1 Open Label, Dose Escalation Study to Evaluate the Effect of Four Doses of MAGE-A3/HPV 16 Trojan Peptides 0001 and 0002 Administered Subcutaneously.
MAGE-A3 HPV-16 vaccine

Head and Neck Neoplasms, Head and Neck Cancer, Wounds, or Ulcer Clinical Trial using silver-releasing dressings

National Taiwan University Hospital - Recruiting 18 years or older.
- The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound.
silver-releasing dressings

Head and Neck Cancer Clinical Trial

Royal Marsden NHS Foundation Trust - Recruiting 18 years or older.
- Investigation of the Role of Functional Imaging in Characterising Radiotherapy Target Volumes and Assessing Disease Response in Patients Undergoing Chemoradiation for Head and Neck Cancer (HNC).

Head and Neck Cancer Clinical Trial using CT-FDG/PET scan of the head-and-neck region

Radboud University - Recruiting 18 years or older.
- Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas..
CT-FDG/PET scan of the head-and-neck region

Cancer of the Head and Neck, or Carcinoma, Adenoid Cystic Clinical Trial using Imatinib

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Phase II Study of Imatinib (Glivec) Administered as a Daily Oral Treatment in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck Overexpressing KIT.
Imatinib

Head and Neck Neoplasms Clinical Trial using BAY 43-9006

Jules Bordet Institute - Recruiting 18 years or older.
- .
BAY 43-9006